Global EditionASIA 中文雙語Fran?ais
    Business
    Home / Business / Companies

    Investors make a beeline for WuXi AppTec shares

    By Cai Xiao | China Daily | Updated: 2018-05-26 11:51
    Share
    Share - WeChat
    Interior view of the headquarters of WuXi Biologics' parent firm, WuXi AppTec, in Shanghai, April 23, 2018. [Photo/IC]

    Leading contract research outsourcing provider WuXi AppTec saw its A-share price jump by the daily limit of 10 percent again on Friday after 13 consecutive trading days of gains to 107.36 yuan ($16.80).

    The market capitalization of the newly listed company totaled 111.9 billion yuan on Friday, ranked fifth by market capitalization among A-share listed pharmaceutical and biotechnology companies.

    Jiangsu Hengrui Medicine Co Ltd, Kangmei Pharmaceutical Co Ltd, Yunnan Baiyao Group Co Ltd and Shanghai Fosun Pharmaceutical Group Co Ltd were the other four firms.

    WuXi AppTec became the most profitable new share as investors could earn about 86,000 yuan for every 1,000 shares based on Friday's stock performance.

    The trading volume of WuXi AppTec totaled 272 million yuan on Friday, compared with 57.6 million yuan on Thursday.

    WuXi AppTec released a statement on Friday afternoon to remind investors of paying attention to the company's operating risks after 14 consecutive trading days of gains.

    "The nation levied no tariffs on imported anti-cancer drugs, as well as imported potency drugs, which also forced domestic drug manufacturers to upgrade their products, creating great opportunities for contract research organizations, with WuXi AppTec taking a lead.

    "Besides, as the market is opening up, there are limited enterprises that are able to offer qualified products, this explains why the company is favored by investors," said Chen Qiaoshan, senior medical analyst at Beijing-based internet consultancy Analysys.

    WuXi AppTech, formerly known as WuXi PharmaTech (Cayman) Inc, was listed at the New York Stock Exchange in 2007 and went private in 2015. WuXi PharmaTech (Cayman) Inc was divided into three companies then: Pharmaceutical Co Ltd listed at China's new third board in 2015, Wuxin Biologics went public in Hong Kong in 2017 and WuXi AppTech, which was listed in May.

    Zheng Yiran contributed to this story.

    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    CLOSE
     
    亚洲无码精品浪潮| 精品无码一区二区三区爱欲九九 | 中文字幕人成人乱码亚洲电影| 精品无码久久久久国产动漫3d| 精品无码综合一区| 无码一区二区三区免费| 亚洲中文字幕无码一去台湾| 中文字幕人妻色偷偷久久 | 一区二区三区无码高清视频| 熟妇人妻无码中文字幕| 国产网红主播无码精品| 在线中文字幕播放| 欧美人妻aⅴ中文字幕| 青春草无码精品视频在线观| 国产爆乳无码一区二区麻豆| 亚洲av日韩av无码| 亚洲中文字幕无码爆乳AV| 日韩a级无码免费视频| 亚洲日韩AV一区二区三区中文| 人妻中文字幕无码专区| 久久人妻AV中文字幕| 亚洲国产av无码精品| AAA级久久久精品无码区| 久久青青草原亚洲av无码app| 亚洲av无码一区二区三区不卡| 曰韩人妻无码一区二区三区综合部 | 最近中文字幕高清字幕在线视频| 亚洲 欧美 国产 日韩 中文字幕 | 无码人妻黑人中文字幕| 中文字幕乱偷无码AV先锋| 中文字幕网伦射乱中文| 中文字幕人妻无码专区| 中文在线最新版天堂8| 最近中文字幕免费2019| 天堂а√在线地址中文在线| 中文字幕久久欲求不满| 亚洲av日韩av高潮潮喷无码| 中文字幕一区一区三区| 成人性生交大片免费看中文| 亚洲VA中文字幕无码毛片| 久久亚洲精品无码aⅴ大香|